Innate immune sensor NOD2 promotes cartilage degradation and osteoarthritis progression by stabilizing TRAF6 in

Yuting Wang1,2,3, Song Li1, Yonghui Dong4

  • 1Department of Orthopaedics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.

JCI Insight
|August 24, 2026
PubMed

Insights

Nucleotide-binding oligomerization domain 2 (NOD2) drives osteoarthritis inflammation and cartilage damage. Inhibiting NOD2 shows promise for disease-modifying osteoarthritis treatment.

Area of Science:

  • Immunology
  • Rheumatology
  • Molecular Biology

Background:

  • Inflammation is key in osteoarthritis (OA) pathogenesis, but mechanisms are unclear.
  • Current OA therapies offer only symptomatic relief, not disease modification.
  • Nucleotide-binding oligomerization domain 2 (NOD2) is an inflammatory pattern recognition receptor.

Purpose of the Study:

  • To investigate the role of NOD2 in OA-associated inflammation and cartilage degradation.
  • To explore NOD2 as a potential therapeutic target for OA.

Main Methods:

  • Assessed NOD2 expression in human and mouse OA cartilage.
  • Used conditional knockout of Nod2 in chondrocytes in vitro and in vivo OA models.
  • Identified downstream mediators of NOD2 signaling.
  • Tested small-molecule NOD2 inhibitors in vivo.

Main Results:

  • NOD2 expression was elevated in OA cartilage.
  • Chondrocyte-specific Nod2 deletion reduced inflammation and protected cartilage in OA models.
  • Tumor necrosis factor receptor-associated factor 6 (TRAF6) was identified as a key mediator.
  • NOD2 inhibition significantly attenuated OA progression in vivo.

Conclusions:

  • NOD2 is a critical regulator of OA inflammation and cartilage breakdown.
  • Targeting NOD2 offers a potential strategy for disease-modifying OA treatment.

Related Concept Videos

T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...
Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...